Research Interests: Molecular pharmacology, physiology and biology of G protein-coupled (heptahelical or seven transmembrane-spanning) receptors; Heart Failure; Cardiovascular Disease; Neurohormonal control of the Circulation; Adrenal Physiology and Pharmacology; Receptors for Adrenaline and Noradrenaline; Catecholamines; Receptors for Angiotensin II; Signal Transduction; Gene Therapy; Transgenic mice and rats; Aldosterone production regulation; Regulation of Adrenergic and Angiotensin Receptors; G protein-coupled receptor Kinases; Beta-Arrestins; Novel "Biased" G protein-coupled Receptor Ligands; Epicardial fat; Atrial Fibrillation; RGS proteins.
Left to right: S. Wertz, J. Pereyra, K. Ferraino, C. Pollard, Dr. Lymperopoulos, A. Perez, R. Valiente, N. Cora, J. Ghandour.
Circle-wise from left to right: N. Cora, Dr. Lymperopoulos, A. Sizova, R. Valiente, A. Carbone, K. Ferraino, J. Borges
Dr. Lymperopoulos is also collaborating with the University Federico II in Naples, Italy (Dr. Rengo`s & Dr. Leosco`s groups), Temple University in Philadelphia, PA (Dr. Koch`s group), the University of Florida in Gainesville, FL (Dr. Sumner`s group), and the University of Miami Miller School of Medicine (Dr. Hare`s group).
Provisional Patent Application entitled: “Methods and Compositions for Treatment of Heart Failure”. Application #: 62128335. Inventors: Lymperopoulos, A.